These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7180065)

  • 1. [5-year controlled therapy study on the prevention of diabetic angiopathy with the platelet-function inhibitor acetylsalicylic acid].
    Zabel-Langhennig R; Ruttmann B; Schiele I; Schäfer W; Aisch W
    Z Gesamte Inn Med; 1982 Oct; 37(19):661-5. PubMed ID: 7180065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study.
    Neri Serneri GG; Coccheri S; Marubini E; Violi F;
    Eur Heart J; 2004 Oct; 25(20):1845-52. PubMed ID: 15474700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive treatment of coronary artery disease in diabetic patients in clinical practice: results of the MITRA study.
    Gitt AK; Schiele R; Wienbergen H; Zeymer U; Schneider S; Gottwik MG; Senges J;
    Acta Diabetol; 2003 Dec; 40 Suppl 2():S343-7. PubMed ID: 14704866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ticlopidine in the secondary prevention of early diabetes-related microangiopathy: protocol of a multicenter therapeutic study (TIMAD study).
    Mirouze J
    Agents Actions Suppl; 1984; 15():230-58. PubMed ID: 6385649
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study.
    DiChiara J; Bliden KP; Tantry US; Hamed MS; Antonino MJ; Suarez TA; Bailon O; Singla A; Gurbel PA
    Diabetes; 2007 Dec; 56(12):3014-9. PubMed ID: 17848625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective analysis of thrombotic events in the European collaboration study on low-dose aspirin in polycythemia (ECLAP).
    Finazzi G;
    Pathol Biol (Paris); 2004 Jun; 52(5):285-8. PubMed ID: 15217715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of macrovascular diseases is reduced in type 1 diabetic patients after more than 5 years successful combined pancreas-kidney transplantation in comparison to kidney transplantation alone.
    Biesenbach G; Königsrainer A; Gross C; Margreiter R
    Transpl Int; 2005 Sep; 18(9):1054-60. PubMed ID: 16101726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic use of acetylsalicylic acid in diabetics].
    Zácková V
    Vnitr Lek; 2003 Dec; 49(12):972-5. PubMed ID: 15040166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Type 2 diabetes mellitus and coronary heart disease].
    Brändle M; Amann FW; Salomon F
    Schweiz Med Wochenschr; 1999 May; 129(18):700-6. PubMed ID: 10407943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial.
    Serebruany VL; Malinin AI; Pokov A; Barsness G; Hanley DF
    Am Heart J; 2008 Jan; 155(1):93.e1-7. PubMed ID: 18082496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet therapy in the prevention of ischaemic stroke.
    Verry M; Panak E; Cazenave JP
    Nouv Rev Fr Hematol (1978); 1994 Jun; 36(3):213-28. PubMed ID: 7971242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.
    Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Alfonso F; Hernández-Antolín R; SanMartín M; Gómez-Hospital JA; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C;
    Eur Heart J; 2007 Aug; 28(16):1946-52. PubMed ID: 17562666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HOPE Study (Heart Outcomes Prevention Evaluation).
    Sleight P
    J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):18-20. PubMed ID: 11967789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low aspirin use in diabetics.
    Akbar DH; Ahmed MM; Siddique AM
    Saudi Med J; 2002 Apr; 23(4):457-60. PubMed ID: 11953775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of naftidrofuryl on platelet aggregation in plasma from aspirin treated patients: an in vitro study.
    Le Dévéhat C; Khodabandehlou T; Mosnier M
    Clin Hemorheol Microcirc; 2000; 22(3):197-204. PubMed ID: 10976713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin attenuates cerebral ischemic injury in diabetic rats.
    Wang T; Fu FH; Han B; Zhu M; Yu X; Zhang LM
    Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):181-5. PubMed ID: 19053022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An antagonist of prostaglandin synthesis in cardiovascular diseases.
    Viinikka L
    Ann Clin Res; 1984; 16(5-6):262-8. PubMed ID: 6398664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The platelet inhibitor problem].
    Straub PW
    Schweiz Med Wochenschr; 1981 Apr; 111(14):478-82. PubMed ID: 7015489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.